Most healthcare organizations provide Telehealth Solutions through their medical plans and patient care philosophy. Urban medical groups provide online portals for patients to access their appointments, message practitioners, review lab results, and schedule future appointments. In rural America medical groups may not be involved, and rural hospitals lack the resources to provide telemedicine solutions to their patients. More importantly, large number of rural individuals do not have access to regular medical care due to proximity and the logistics of traveling hundreds of miles for a single doctors appointment. The need for Rural Telemedicine as a communication methodology between rural resident and medical care has never been greater than during the Covid-19 pandemic. In urban areas Telehealth is addressing the medical needs of patients that are aging and more prone to diabetes, overweight, high blood pressure, and high cholesterol through monitoring and reporting.

Read on eventbrite.com

As reimbursements shift from volume based to value based, healthcare organizations are becoming more responsible for providing the resources necessary to meet the needs of a given population. Aligning quality of care with the appropriate level of care and services becomes pertinent to healthcare organizations’ bottom line. It is imperative for healthcare leaders to develop programs that offer underserved communities an opportunity for a healthier tomorrow. Several pioneer organizations have developed population health improvement models such as Accountable Care Organizations that force them to take responsibility for the beneficiaries they are serving. As the acuity of care increases, healthcare leaders must coordinate equitable care and properly address social determinants of health. The focus is no longer treating patients, but proactively keeping patients out of the acute healthcare setting and providing care in the community. Developing population health management into a tangible measure continues to be a challenge for all healthcare organizations across the country. How to properly reduce costs while improving the quality and access of care in communities that lack the resources and education to care for themselves and prevent acute health issues and substantive chronic disease continues to be a major hurdle in population health adoption.

Read on eventbrite.com

As reimbursements shift from volume based to value based, healthcare organizations are becoming more responsible for providing the resources necessary to meet the needs of a given population. Aligning quality of care with the appropriate level of care and services becomes pertinent to healthcare organizations’ bottom line. It is imperative for healthcare leaders to develop programs that offer underserved communities an opportunity for a healthier tomorrow. Several pioneer organizations have developed population health improvement models such as Accountable Care Organizations that force them to take responsibility for the beneficiaries they are serving. As the acuity of care increases, healthcare leaders must coordinate equitable care and properly address social determinants of health. The focus is no longer treating patients, but proactively keeping patients out of the acute healthcare setting and providing care in the community. Developing population health management into a tangible measure continues to be a challenge for all healthcare organizations across the country. How to properly reduce costs while improving the quality and access of care in communities that lack the resources and education to care for themselves and prevent acute health issues and substantive chronic disease continues to be a major hurdle in population health adoption.

Read on eventbrite.co.uk

Join us in a discussion on how crisis line services can assist in closing gaps and build bridges for people who experience mental, emotional, and behavioral health and substance use concerns which do not replace community services, but fill in the gaps and create connections to support people in communities. We will hear from two speakers: Molly Brack, Clinical Director at the Agora Crisis Center and Wendy Linebrink-Allison, Program Manager of the NM Crisis Line. Also joining us is Elizabeth Glantz, 988 Project Manager with NM Behavioral Health Services Division. Elizabeth will provide an overview of the State of New Mexico’s Behavioral Health Services Division’s approach to 988 and how they are implementing the Crisis Now crisis response model in alignment with the 988 roll-out.

Read on eventbrite.com

Hospitals are redefining how and where they deliver care to patients, and many are seeing the hospital-at-home model as a promising approach to improve value. Hospital-at-home enables some patients who need acute-level care to receive care in their homes, rather than in a hospital. This care delivery model has been shown to reduce costs, improve outcomes and enhance the patient experience. Essential to the hospital at home model is virtual technology, augmented by in person nursing care, allowing medical staff to remotely monitor the health of patients.

Read on eventbrite.com

Partially as a result of the COVID-19 pandemic, patients have demonstrated increasing interest in addressing health care issues from their homes, through telehealth visits with their doctors, or home-based screening, testing, or monitoring devices. Continuous glucose monitors (CGMs) help patients self-manage their diabetes from home. This presentation will address a professional practice gap in knowledge about the broader use of CGMs in primary care patients with type 2 diabetes, addressing patient preference for home-based self-management technology, as well as a broader application of CGMs, i.e., prior to insulin therapy initiation.

Read on my.amga.org

Welcome to the age of constraints, most cannot afford either the cost or deployment time of large complex systems, you likely already own platform automation capabilities that can drive impact toward transformative healthcare outcomes. This discussion will focus on how your data can drive the automation of outcomes that quickly align with the principles of the quintuple aim and create the agility to address future challenges. 

Read on chimecentral.org

Over the past couple of years, the engineered biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules and controllable therapeutics grows exponentially.

The therapeutic potential of novel synthetic units is huge, but challenges remain in demonstrating proof-of-concept, developing assays, functional characterization, manufacturing scale-up, and identifying therapeutic applications for commercial development.

Returning for the 2nd year, the Synthetic Biology-Based Therapies Summit is the industry-defining forum made exclusively for leaders in the synthetic and engineered biology space, focusing on the technical challenges that lie ahead in the path towards commercialization.

Learn from industry trailblazers at Arsenal Biosciences, bit.bio, MIT, Novome Bio, Strand Therapeutics, Synlogic and more, to support your efforts in developing safe and effective synthetic biology-based therapeutics.

Prices:

Conference + Workshop Day - Industry Pricing USD 3497.00

Conference Only - Industry Pricing USD 2599.00

Conference + Workshop Day - Service Provider Pricing USD 4297.00

Conference Only - Service Provider Pricing USD 3199.00

Conference + Workshop Day - Academic Pricing USD 2897.00

Conference Only - Academic Pricing USD 2199.00

Category: Conferences | Science, Health & Medicine | Pharmaceuticals | Drug Development

Dates and Time: Starts: Tue, Dec 13, 2022 ( 9:00 AM) and Ends: Thu, Dec 15, 2022 ( 5:00 PM)

Venue details: Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street, Boston, Massachusetts, 02128, United States

Over the past four months, through a partnership with the Korean Startup Center (KSC), IntuitiveX alongside University of Washington - CoMotion and Washington Technology Innovation Alliance (WTIA) have been providing five Korean companies with strategic guidance, resources and a cohort of mentors to support with their commercialization efforts within the U.S. as they prepare for U.S. market entry.

On December 13, join us for an in-person and virtual showcase where the following five companies Deep Bio, Olive Healthcare, VNTC, Orange Biomed, and Mezoo will share how their novel healthcare technologies are driving innovation to solve unmet challenges in healthcare. After the pitches, join us for networking and discussion. This will be an opportunity to connect with the five Korean startups and identify opportunities to collaborate with them as potential customers, strategic partners, advisors, and more.

Read on eventbrite.com

In 2022, the International Atomic Energy Agency (IAEA) will hold the International Conference on Integrated Medical Imaging in Cardiovascular Diseases (IMIC-2022), building on the success of the IMIC-2013 and IMIC-2016 conferences. Non-communicable diseases (NCDs) are steadily increasing both in developed and developing countries. Cardiovascular diseases (CVDs) are a dominant subgroup of NCDs and account for the highest proportional mortality among all NCDs.

Read on iaea.org